Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.
A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.
It’s a lot easier to fight addiction when you have a stable place to live.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
A new report warns the crisis could see a third wave if synthetic opioids continue to move into new U.S. markets.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
The first national study of opioid use disorder recovery found that staying off such drugs often requires great effort and various services.
Check out this long read about the effects of the opioid epidemic on the nation’s criminal justice system.
Bobby Brown’s mental and physical challenges transformed him into someone with a healthier, happier outlook on life.
Researchers reviewed numerous studies to inform their detailed tips for better engaging people who inject opioid drugs in hepatitis C care.
Dorothy Horton, PsyD, answers your questions in her latest Ask Doctor Dee column.
Researchers modeled the differences between testing focused on baby boomers versus universal screening.
Researchers analyzed data on more than a quarter of a million teens and young adults attending federally qualified health centers.
The Canadian harm reduction center will provide medical marijuana at little to no cost as a safer alternative to opioids.
The harm reduction facility could be the first in the nation.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.